Skip to content
healthcare.dev

carbamazepine

NDC 70771-1469, carbamazepine, tablet, extended release, from Zydus Lifesciences Limited.

Product NDC
70771-1469
Status
Listed
Labeler
Zydus Lifesciences Limited
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA205571
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1469 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CARBAMAZEPINE200 mg/1

Pharmacologic classes

Cytochrome P450 1A2 Inducers [MoA]; Cytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 2C19 Inducers [MoA]; Cytochrome P450 2C9 Inducers [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]; Mood Stabilizer [EPC]

Package NDCNDC-11Package
70771-1469-170771146901100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1469-1)
70771-1469-37077114690330 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1469-3)
70771-1469-47077114690410 BLISTER PACK in 1 CARTON (70771-1469-4) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
70771-1469-97077114690990 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1469-9)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d10e5f83-56db-4bc9-8c51-150a2e3e20ea

Use it

Look up 70771-1469 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1469 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70771-1469. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.